Rajiv Anant Patel
Private Equity Investor chez Farallon Capital Management (Private Equity)
Profil
Rajiv Anant Patel is a Partner at Farallon Capital Management (Private Equity) since 1997.
He was a Director at Flowonix Medical, Inc. and an Investment Banker at Donaldson, Lufkin & Jenrette Securities Corp.
He was also a Non-Executive Director at Nexvet Biopharma Plc from 2015 to 2017 and an Independent Non-Executive Director at Nexvet Australia Pty Ltd.
Mr. Patel holds an undergraduate degree from Cornell University and an MBA from Stanford Graduate School of Business.
Postes actifs de Rajiv Anant Patel
| Sociétés | Poste | Début |
|---|---|---|
Farallon Capital Management (Private Equity)
 Farallon Capital Management (Private Equity) Investment ManagersFinance Farallon Capital Management (Private Equity) (Farallon Capital) is a private equity subsidiary of Farallon Capital Management LLC founded in 1986 by Thomas Fahr Steyer. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/01/1997 |
Anciens postes connus de Rajiv Anant Patel
| Sociétés | Poste | Fin |
|---|---|---|
| NEXVET BIOPHARMA PUBLIC LIMITED CO | Directeur/Membre du Conseil | 31/07/2017 |
| Donaldson, Lufkin & Jenrette Securities Corp. | Corporate Officer/Principal | - |
Flowonix Medical, Inc.
 Flowonix Medical, Inc. Medical SpecialtiesHealth Technology Flowonix Medical, Inc. designs and develops proprietary implantable pumps. It provides implantable intrathecal pumps to help manage chronic pain for cancer patients and patients with back pain. The company was founded in 2005 and is headquartered in Mt. Olive, NJ. | Directeur/Membre du Conseil | - |
Nexvet Australia Pty Ltd.
 Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Directeur/Membre du Conseil | - |
Formation de Rajiv Anant Patel
| Cornell University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
| Donaldson, Lufkin & Jenrette Securities Corp. | Finance |
Farallon Capital Management (Private Equity)
Farallon Capital Management (Private Equity) Investment ManagersFinance Farallon Capital Management (Private Equity) (Farallon Capital) is a private equity subsidiary of Farallon Capital Management LLC founded in 1986 by Thomas Fahr Steyer. The firm is headquartered in San Francisco, California. | Finance |
Nexvet Biopharma Plc
 Nexvet Biopharma Plc Pharmaceuticals: MajorHealth Technology Nexvet Biopharma Plc engaged in the provision of integrated biopharmaceutical business. It focused on transforming the therapeutic market for companion animals, such as dogs and cats, by developing and commercializing novel, species-specific biologics. The company was founded in September 2014 and was headquartered in Dublin, Ireland. | Health Technology |
Nexvet Australia Pty Ltd.
Nexvet Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Nexvet Australia Pty Ltd. operates as a global clinical-stage biopharmaceutical company that develops and distributes medicines for companion animals. The firm focuses on transforming the therapeutic market by developing and commercializing novel biologic therapies, including products derived from its PETization technology. PETization is designed to rapidly create monoclonal antibodies that are recognized as “self” by a patient’s immune system. The company was founded by Mark Heffernan, Christopher Nigel Brown and David Gearing in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
Flowonix Medical, Inc.
Flowonix Medical, Inc. Medical SpecialtiesHealth Technology Flowonix Medical, Inc. designs and develops proprietary implantable pumps. It provides implantable intrathecal pumps to help manage chronic pain for cancer patients and patients with back pain. The company was founded in 2005 and is headquartered in Mt. Olive, NJ. | Health Technology |
